Phase 1 Solid Tumor Malignancy Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients
Solid Tumor Malignancy
Chengdu New Radiomedicine Technology Co. LTD.132 enrolled2 locationsNCT06911489
Recruiting
Phase 1
A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients
Solid Tumor Malignancy
Shanghai Institute Of Biological Products156 enrolled1 locationNCT06985368